Trial Profile
A Human Laboratory Assessment of the Safety and Potential Efficacy of SYN117 (Nepicastat) in Cocaine-dependent Volunteers Receiving Cocaine
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 23 Jan 2018
Price :
$35
*
At a glance
- Drugs Nepicastat (Primary)
- Indications Cocaine-related disorders
- Focus Adverse reactions
- Sponsors Biotie Therapies Corp.
- 30 Jan 2015 Results published in a Biotie Therapies media release.
- 24 Jun 2014 New trial record